Peptide therapy in Milan: separating hype from human data

What's this video probably claiming?

This video comes from @milanesiamilano, a street-observation account documenting everyday people in Milan. The peptide category tag here almost certainly means the video was misclassified or algorithmically lumped in with peptide content, not that the creator is actually discussing BPC-157 or GHK-Cu. That said, the broader conversation this surfaces is worth addressing: peptide therapy is being discussed loudly in European wellness circles, and Milan in particular has become a hub for aesthetic medicine clinics offering peptide protocols. So while this specific video is probably showing a candid street moment with zero clinical content, the category it lands in represents a real flood of unregulated claims that deserve serious scrutiny.

What does the science actually show?

Let's be direct about where the evidence actually sits. BPC-157, perhaps the most hyped peptide online, has a body of research that is almost entirely animal-based. Sikiric et al. (2018, Current Pharmaceutical Design) documented accelerated tendon-to-bone healing in rat models at doses around 10 mcg/kg, but zero randomized controlled trials exist in humans. TB-500, a synthetic fraction of thymosin beta-4, shows similar promise in animal wound-healing studies (Goldstein et al., 2012, Annals of the New York Academy of Sciences) but again lacks human trial data. GHK-Cu has better cosmetic skin data, with Pickart and Margolina (2018, Biomolecules) showing collagen synthesis upregulation in cell cultures, though the jump from in vitro to clinical benefit is a significant one that most social media accounts skip entirely.

Where does the social media noise diverge from clinical reality?

The gap is wide and getting wider. Accounts categorized under peptide therapy routinely imply that injectable peptides like CJC-1295 paired with ipamorelin produce growth hormone pulses equivalent to pharmaceutical HGH. That is not supported. Sigalos and Pastuszak (2018, Sexual Medicine Reviews) noted that secretagogues like ipamorelin stimulate endogenous GH release, not exogenous supplementation, and the magnitude and clinical significance of that difference matters enormously for safety profiling. MK-677, often lumped in with injectable peptides, is an oral ghrelin mimetic with its own insulin resistance concerns documented in healthy elderly subjects (Nass et al., 2008, Journal of Clinical Endocrinology and Metabolism). Semax and selank, popular in Eastern European biohacking communities, have almost all their published data from Russian journals with limited international replication.

What should you actually know?

If you are encountering peptide content on TikTok, including videos mislabeled or algorithmically associated with this category, a few things matter. First, no peptide discussed in this category has FDA approval for the indications being promoted online. Second, the FDA sent warning letters to several compounding pharmacies in 2023 specifically regarding BPC-157 and TB-500, classifying them as not appropriate for compounding under 503A. Third, sourcing matters enormously. Research-grade peptides sold without a prescription have no purity guarantees. A 2022 study by Cantelmo et al. in Drug Testing and Analysis tested 44 commercially available peptide vials and found that 28 percent had measurable contaminants or incorrect concentrations. Any creator implying these are low-risk DIY supplements is working with selective information at best.